Clinical Trials

ELIAS Animal Health has developed a unique immunotherapy treatment protocol which may permit the dog’s immune system to attack its own cancer cells. ELIAS Cancer Immunotherapy (ECI®)—a vaccine-enhanced adoptive cell therapy—has demonstrated effectiveness in clinical trials in canines, while avoiding or minimizing the need for chemotherapy or radiation treatment.

Canine Osteosarcoma: ECI® combined with novel adjuvant and limb-spare surgery

Enrollment for this study (ECIP-OSA-01) is now open.